As of 2025-07-05, the Intrinsic Value of Sarana Meditama Metropolitan Tbk PT (SAME.JK) is 113.37 IDR. This SAME.JK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 250.00 IDR, the upside of Sarana Meditama Metropolitan Tbk PT is -54.70%.
The range of the Intrinsic Value is 74.77 - 192.01 IDR
Based on its market price of 250.00 IDR and our intrinsic valuation, Sarana Meditama Metropolitan Tbk PT (SAME.JK) is overvalued by 54.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 74.77 - 192.01 | 113.37 | -54.7% |
| DCF (Growth 10y) | 128.45 - 287.74 | 181.29 | -27.5% |
| DCF (EBITDA 5y) | 233.41 - 441.38 | 293.74 | 17.5% |
| DCF (EBITDA 10y) | 273.46 - 533.99 | 352.39 | 41.0% |
| Fair Value | 29.07 - 29.07 | 29.07 | -88.37% |
| P/E | 16.54 - 72.24 | 39.19 | -84.3% |
| EV/EBITDA | 40.85 - 213.30 | 127.65 | -48.9% |
| EPV | (98.05) - (110.39) | (104.22) | -141.7% |
| DDM - Stable | 7.69 - 18.63 | 13.16 | -94.7% |
| DDM - Multi | 64.95 - 125.17 | 85.83 | -65.7% |
| Market Cap (mil) | 4,288,970.00 |
| Beta | 0.70 |
| Outstanding shares (mil) | 17,155.88 |
| Enterprise Value (mil) | 5,153,852.00 |
| Market risk premium | 7.88% |
| Cost of Equity | 12.10% |
| Cost of Debt | 5.00% |
| WACC | 10.39% |